Markets


Wall Street’s Take on Two Biotech Rockets: Mylan N.V. (MYL) and CytomX Therapeutics Inc (CTMX)

Cantor cautiously welcomes MYL’s FDA success as EPS upside; Cowen applauds CTMX’s Probody technology.

Analysts Like What They See Between Tesla Inc (TSLA) Model 3 Revenue Possibilities and Fitbit Inc’s (FIT) Expanding Footprint in Digital Health

Tesla’s Got a Lot of Exciting Irons in the Fire Tesla Inc (NASDAQ:TSLA) encouragingly has indicated upside to its deliveries for the third …

Real Goods Solar, Inc. (RGSE) Wows Investors – Here’s Why

Real Goods Solar, Inc. (NASDAQ:RGSE) shares tripled in less than one hour after the markets opened today.

Gilead Sciences, Inc. (GILD) Presents Phase 3 Clinical Data in HIV-1 at IDWeek 2017

Gilead Sciences, Inc. (NASDAQ:GILD) announced detailed 48-week results from a Phase 3 study (Study 1878) evaluating the efficacy and safety of switching virologically suppressed …

Mylan N.V. (MYL) Gain Is Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Pain

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares are diving nearly 15% in Wednesday’s trading session, following the news that competitor Mylan N.V.

Quant Investing Guru Jim Simons Rolls Out the Red Carpet for Two Drug Makers: Celsion Corporation (CLSN) and NewLink Genetics Corp (NLNK)

Take a gander at bullish Q2 plays in biotech from one of the richest men in the business.

Valeant Pharmaceuticals Intl Inc (VRX) Keeps Fighting to Turnaround Debt Overhang, RedHill Biopharma Ltd – ADR (RDHL) Scares Investors to Save $14 Million; Analysts Dive In

Valeant’s comeback progresses with new notes offering; RedHill ups the risk ante in favor of time/money.

Cesca Therapeutics Inc (KOOL) Rides Higher on Biotech Waves – Here’s Why

Cesca Therapeutics Inc (NASDAQ:KOOL) announced today it has received Notice of Allowance for U.S.

Investors Are Racing to Buy Celsion Corporation (CLSN) Shares; Here’s Why

It’s a very rewarding trading day for shareholders of Celsion Corporation (NASDAQ:CLSN) with shares up over 130%, making the stock Wall Street’s bull …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts